HeLa
Resource Report
Resource Website
10000+ mentions
Discontinued
|
ICLC Cat# HTL95023, RRID:CVCL_0030
|
Homo sapiens (Human)
|
Human papillomavirus-related endocervical adenocarcinoma
|
Miscellaneous: HeLa is the most frequent contributor to cell lines contamination., Anecdotal: Was flown since the 1960s on at least ten different space missions: Korabl-Sputnik-2, Vostok-1, Vostok-4, Vostok-5 and Vostok-6, Voshkod 1 and Zond-5, Discoverer XVIII, Progress M-35/Mir and Shuttle STS-89., Anecdotal: The HeLa cell line and its story inspired Australian artist Cynthia Verspaget to embark in 2003 on a artistic project 'The Anarchy Cell Line' (TAnCL) where she mixed her blood with HeLa cells. This work later spawned a PhD thesis (CelloPub=CLPUB00376) where among other things she makes the observation that two main taxonomical distinctions present in the zombie, living/dead and human/nonhuman, are also present in the HeLa cell line., Anecdotal: The fascinating story of the HeLa cell line and of Henrietta Lacks from whom these cells originate are described in the book of Rebecca Skloot (CelloPub=CLPUB00377)., Anecdotal: The HeLa cell line which was established in February 1951 is the oldest human immortal cell line., Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Virology: HeLa has 5 five HPV18 integration sites: three on normal chromosomes 8 at 8q24 and two on derivative chromosomes, der(5)t(5;22;8)(q11;q11q13;q24) and der(22)t(8;22) (q24;q13)., Population: African American., Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982)., Part of: MD Anderson Cell Lines Project., Part of: Human Protein Atlas, Cell Atlas panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Space-flown cell line (cellonaut).
|
PMID:77569
PMID:1246620
PMID:1522048
PMID:2983228
PMID:2990217
PMID:3028716
PMID:3180844
PMID:3371749
PMID:3518877
PMID:4942173
PMID:5668122
PMID:6256643
PMID:6358339
PMID:6401685
PMID:6825208
PMID:6935474
PMID:8380785
PMID:9892199
PMID:10423141
PMID:11416159
PMID:11668190
PMID:12001993
PMID:12661003
PMID:12793746
PMID:13052828
PMID:13207312
PMID:13261081
PMID:14031339
PMID:14185313
PMID:15302935
PMID:15531914
PMID:15901131
PMID:16589695
PMID:16957166
PMID:17311676
PMID:19450234
PMID:19722756
PMID:19941903
PMID:21269460
PMID:21937730
PMID:22068331
PMID:22278370
PMID:22412903
PMID:23205564
PMID:23336012
PMID:23925224
PMID:23925245
PMID:24134916
PMID:24618588
PMID:24696503
PMID:24908793
PMID:25485619
PMID:25807930
PMID:25877200
PMID:25894527
PMID:25960936
PMID:26554430
PMID:26589293
PMID:27397505
PMID:28078501
PMID:28196595
PMID:28261610
PMID:28601559
PMID:29156801
PMID:30175587
PMID:30778230
PMID:30787054
PMID:30894373
PMID:31068700
PMID:31433507
PMID:31790455
PMID:33389257
PMID:35198691
PMID:35839778
PMID:37543987
|
Cancer cell line
|
Female |
HELA, Hela, He La, He-La, HeLa-CCL2, Henrietta Lacks cells, Helacyton gartleri |
ICLC |
HTL95023 |
BTO:BTO_0000567,
CLO:CLO_0003684,
CLO:CLO_0050910,
EFO:EFO_0001185,
MCCL:MCC:0000219,
CLDB:cl1594,
CLDB:cl1595,
CLDB:cl1596,
CLDB:cl1597,
CLDB:cl1599,
CLDB:cl1600,
CLDB:cl1601,
CLDB:cl1603,
Abcam:ab255448,
Abcam:ab255928,
Abcam:ab260075,
Abcam:ab271142,
Abcam:ab275466,
AddexBio:C0008001/44,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-3610,
ATCC:CCL-2,
ATCC:CRL-7923,
ATCC:CRM-CCL-2,
BCRC:60005,
BCRJ:0100,
BEI_Resources:ARP-153,
BioGRID_ORCS_Cell_line:95,
BioSample:SAMN03471148,
BioSample:SAMN03472333,
BioSample:SAMN10989629,
cancercelllines:CVCL_0030,
CCLV:CCLV-RIE 0082,
CCRID:1101HUM-PUMC000011,
CCRID:1101HUM-PUMC000332,
CCRID:1102HUM-NIFDC00057,
CCRID:3101HUMSCSP504,
CCRID:3101HUMTCHu187,
CCRID:4201HUM-CCTCC00009,
CCRID:5301HUM-KCB90024YJ,
CCTCC:GDC0009,
Cell_Model_Passport:SIDM00846,
ChEMBL-Cells:CHEMBL3308376,
ChEMBL-Targets:CHEMBL399,
CLS:300194,
Cosmic:760219,
Cosmic:760490,
Cosmic:801357,
Cosmic:809231,
Cosmic:877477,
Cosmic:911999,
Cosmic:925354,
Cosmic:928907,
Cosmic:944113,
Cosmic:1019309,
Cosmic:1057766,
Cosmic:1071911,
Cosmic:1131525,
Cosmic:1193029,
Cosmic:1201779,
Cosmic:1324208,
Cosmic:1336880,
Cosmic:1571796,
Cosmic:2301539,
Cosmic:2660190,
Cosmic:2750874,
Cosmic:2791019,
Cosmic:2816214,
Cosmic-CLP:1298134,
dbGAP:phs000640.v4.p1,
DepMap:ACH-001086,
DSMZ:ACC-57,
DSMZCellDive:ACC-57,
ECACC:93021013,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
EGA:phs000640,
FCS-free:44-2-47-1-8-9,
GDSC:1298134,
GEO:GSM113863,
GEO:GSM226739,
GEO:GSM226875,
GEO:GSM253298,
GEO:GSM436128,
GEO:GSM436129,
GEO:GSM501788,
GEO:GSM722574,
GEO:GSM722575,
GEO:GSM723055,
GEO:GSM723056,
GEO:GSM1088663,
GEO:GSM1088664,
GEO:GSM1088665,
GEO:GSM1088666,
GEO:GSM1374528,
GEO:GSM1669875,
GEO:GSM1881473,
GEO:GSM1881474,
GEO:GSM1881475,
GEO:GSM7701367,
GEO:GSM7701368,
Hysigen:TCH-C193,
ICLC:HTL95023,
IGRhCellID:HeLA,
IZSLER:BS TCL 20,
JCRB:JCRB9004,
KCB:KCB 86019YJ,
KCB:KCB 90024YJ,
KCLB:10002,
LINCS_HMS:50061,
LINCS_LDP:LCL-1512,
Lonza:51,
MeSH:D006367,
NCBI_Iran:C115,
PharmacoDB:HeLa_536_2019,
PRIDE:PRD000007,
PRIDE:PRD000032,
PRIDE:PRD000123,
PRIDE:PRD000124,
PRIDE:PRD000345,
PRIDE:PRD000376,
PRIDE:PRD000525,
PRIDE:PRD000526,
PRIDE:PRD000527,
PRIDE:PXD000013,
PRIDE:PXD000243,
PRIDE:PXD000252,
PRIDE:PXD000279,
PRIDE:PXD000396,
PRIDE:PXD000474,
PRIDE:PXD000589,
PRIDE:PXD000661,
PRIDE:PXD000680,
PRIDE:PXD000759,
PRIDE:PXD000883,
PRIDE:PXD000895,
PRIDE:PXD000900,
PRIDE:PXD000953,
PRIDE:PXD000954,
PRIDE:PXD000999,
PRIDE:PXD001047,
PRIDE:PXD001118,
PRIDE:PXD001154,
PRIDE:PXD001175,
PRIDE:PXD001249,
PRIDE:PXD001258,
PRIDE:PXD001259,
PRIDE:PXD001278,
PRIDE:PXD001305,
PRIDE:PXD001374,
PRIDE:PXD001381,
PRIDE:PXD001396,
PRIDE:PXD001441,
PRIDE:PXD001541,
PRIDE:PXD001548,
PRIDE:PXD001574,
PRIDE:PXD001660,
PRIDE:PXD001781,
PRIDE:PXD001798,
PRIDE:PXD001805,
PRIDE:PXD001806,
PRIDE:PXD001810,
PRIDE:PXD001863,
PRIDE:PXD001907,
PRIDE:PXD002001,
PRIDE:PXD002039,
PRIDE:PXD002066,
PRIDE:PXD002252,
PRIDE:PXD002277,
PRIDE:PXD002378,
PRIDE:PXD002383,
PRIDE:PXD002395,
PRIDE:PXD002572,
PRIDE:PXD002591,
PRIDE:PXD002704,
PRIDE:PXD002844,
PRIDE:PXD002880,
PRIDE:PXD003186,
PRIDE:PXD003209,
PRIDE:PXD003258,
PRIDE:PXD003370,
PRIDE:PXD003503,
PRIDE:PXD003530,
PRIDE:PXD003560,
PRIDE:PXD003792,
PRIDE:PXD003813,
PRIDE:PXD003909,
PRIDE:PXD003913,
PRIDE:PXD003917,
PRIDE:PXD003924,
PRIDE:PXD004182,
PRIDE:PXD004271,
PRIDE:PXD004273,
PRIDE:PXD004452,
PRIDE:PXD004613,
PRIDE:PXD004736,
PRIDE:PXD004900,
PRIDE:PXD004914,
PRIDE:PXD004933,
PRIDE:PXD004934,
PRIDE:PXD004940,
PRIDE:PXD004995,
PRIDE:PXD005018,
PRIDE:PXD005107,
PRIDE:PXD005181,
PRIDE:PXD005346,
PRIDE:PXD005349,
PRIDE:PXD005366,
PRIDE:PXD005466,
PRIDE:PXD005509,
PRIDE:PXD005572,
PRIDE:PXD005712,
PRIDE:PXD005955,
PRIDE:PXD006112,
PRIDE:PXD006293,
PRIDE:PXD012045,
PRIDE:PXD012188,
PRIDE:PXD013064,
PRIDE:PXD023271,
PRIDE:PXD023835,
PRIDE:PXD027504,
PRIDE:PXD029773,
PRIDE:PXD030304,
Progenetix:CVCL_0030,
PubChem_Cell_line:CVCL_0030,
RCB:RCB0007,
RCB:RCB3680,
SKY/M-FISH/CGH:5351,
TKG:TKG 0331,
TOKU-E:1434,
Ubigene:YC-A012,
Wikidata:Q847482 |
|
|
CVCL_0030 |
2026-07-25 04:40:44 |
39012 |
HeLa
Resource Report
Resource Website
10000+ mentions
Discontinued
|
Abcam Cat# ab255928, RRID:CVCL_0030
|
Homo sapiens (Human)
|
Human papillomavirus-related endocervical adenocarcinoma
|
Miscellaneous: HeLa is the most frequent contributor to cell lines contamination., Anecdotal: Was flown since the 1960s on at least ten different space missions: Korabl-Sputnik-2, Vostok-1, Vostok-4, Vostok-5 and Vostok-6, Voshkod 1 and Zond-5, Discoverer XVIII, Progress M-35/Mir and Shuttle STS-89., Anecdotal: The HeLa cell line and its story inspired Australian artist Cynthia Verspaget to embark in 2003 on a artistic project 'The Anarchy Cell Line' (TAnCL) where she mixed her blood with HeLa cells. This work later spawned a PhD thesis (CelloPub=CLPUB00376) where among other things she makes the observation that two main taxonomical distinctions present in the zombie, living/dead and human/nonhuman, are also present in the HeLa cell line., Anecdotal: The fascinating story of the HeLa cell line and of Henrietta Lacks from whom these cells originate are described in the book of Rebecca Skloot (CelloPub=CLPUB00377)., Anecdotal: The HeLa cell line which was established in February 1951 is the oldest human immortal cell line., Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Virology: HeLa has 5 five HPV18 integration sites: three on normal chromosomes 8 at 8q24 and two on derivative chromosomes, der(5)t(5;22;8)(q11;q11q13;q24) and der(22)t(8;22) (q24;q13)., Population: African American., Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982)., Part of: MD Anderson Cell Lines Project., Part of: Human Protein Atlas, Cell Atlas panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Space-flown cell line (cellonaut).
|
PMID:77569
PMID:1246620
PMID:1522048
PMID:2983228
PMID:2990217
PMID:3028716
PMID:3180844
PMID:3371749
PMID:3518877
PMID:4942173
PMID:5668122
PMID:6256643
PMID:6358339
PMID:6401685
PMID:6825208
PMID:6935474
PMID:8380785
PMID:9892199
PMID:10423141
PMID:11416159
PMID:11668190
PMID:12001993
PMID:12661003
PMID:12793746
PMID:13052828
PMID:13207312
PMID:13261081
PMID:14031339
PMID:14185313
PMID:15302935
PMID:15531914
PMID:15901131
PMID:16589695
PMID:16957166
PMID:17311676
PMID:19450234
PMID:19722756
PMID:19941903
PMID:21269460
PMID:21937730
PMID:22068331
PMID:22278370
PMID:22412903
PMID:23205564
PMID:23336012
PMID:23925224
PMID:23925245
PMID:24134916
PMID:24618588
PMID:24696503
PMID:24908793
PMID:25485619
PMID:25807930
PMID:25877200
PMID:25894527
PMID:25960936
PMID:26554430
PMID:26589293
PMID:27397505
PMID:28078501
PMID:28196595
PMID:28261610
PMID:28601559
PMID:29156801
PMID:30175587
PMID:30778230
PMID:30787054
PMID:30894373
PMID:31068700
PMID:31433507
PMID:31790455
PMID:33389257
PMID:35198691
PMID:35839778
PMID:37543987
|
Cancer cell line
|
Female |
HELA, Hela, He La, He-La, HeLa-CCL2, Henrietta Lacks cells, Helacyton gartleri |
Abcam |
ab255928 |
BTO:BTO_0000567,
CLO:CLO_0003684,
CLO:CLO_0050910,
EFO:EFO_0001185,
MCCL:MCC:0000219,
CLDB:cl1594,
CLDB:cl1595,
CLDB:cl1596,
CLDB:cl1597,
CLDB:cl1599,
CLDB:cl1600,
CLDB:cl1601,
CLDB:cl1603,
Abcam:ab255448,
Abcam:ab255928,
Abcam:ab260075,
Abcam:ab271142,
Abcam:ab275466,
AddexBio:C0008001/44,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-3610,
ATCC:CCL-2,
ATCC:CRL-7923,
ATCC:CRM-CCL-2,
BCRC:60005,
BCRJ:0100,
BEI_Resources:ARP-153,
BioGRID_ORCS_Cell_line:95,
BioSample:SAMN03471148,
BioSample:SAMN03472333,
BioSample:SAMN10989629,
cancercelllines:CVCL_0030,
CCLV:CCLV-RIE 0082,
CCRID:1101HUM-PUMC000011,
CCRID:1101HUM-PUMC000332,
CCRID:1102HUM-NIFDC00057,
CCRID:3101HUMSCSP504,
CCRID:3101HUMTCHu187,
CCRID:4201HUM-CCTCC00009,
CCRID:5301HUM-KCB90024YJ,
CCTCC:GDC0009,
Cell_Model_Passport:SIDM00846,
ChEMBL-Cells:CHEMBL3308376,
ChEMBL-Targets:CHEMBL399,
CLS:300194,
Cosmic:760219,
Cosmic:760490,
Cosmic:801357,
Cosmic:809231,
Cosmic:877477,
Cosmic:911999,
Cosmic:925354,
Cosmic:928907,
Cosmic:944113,
Cosmic:1019309,
Cosmic:1057766,
Cosmic:1071911,
Cosmic:1131525,
Cosmic:1193029,
Cosmic:1201779,
Cosmic:1324208,
Cosmic:1336880,
Cosmic:1571796,
Cosmic:2301539,
Cosmic:2660190,
Cosmic:2750874,
Cosmic:2791019,
Cosmic:2816214,
Cosmic-CLP:1298134,
dbGAP:phs000640.v4.p1,
DepMap:ACH-001086,
DSMZ:ACC-57,
DSMZCellDive:ACC-57,
ECACC:93021013,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
EGA:phs000640,
FCS-free:44-2-47-1-8-9,
GDSC:1298134,
GEO:GSM113863,
GEO:GSM226739,
GEO:GSM226875,
GEO:GSM253298,
GEO:GSM436128,
GEO:GSM436129,
GEO:GSM501788,
GEO:GSM722574,
GEO:GSM722575,
GEO:GSM723055,
GEO:GSM723056,
GEO:GSM1088663,
GEO:GSM1088664,
GEO:GSM1088665,
GEO:GSM1088666,
GEO:GSM1374528,
GEO:GSM1669875,
GEO:GSM1881473,
GEO:GSM1881474,
GEO:GSM1881475,
GEO:GSM7701367,
GEO:GSM7701368,
Hysigen:TCH-C193,
ICLC:HTL95023,
IGRhCellID:HeLA,
IZSLER:BS TCL 20,
JCRB:JCRB9004,
KCB:KCB 86019YJ,
KCB:KCB 90024YJ,
KCLB:10002,
LINCS_HMS:50061,
LINCS_LDP:LCL-1512,
Lonza:51,
MeSH:D006367,
NCBI_Iran:C115,
PharmacoDB:HeLa_536_2019,
PRIDE:PRD000007,
PRIDE:PRD000032,
PRIDE:PRD000123,
PRIDE:PRD000124,
PRIDE:PRD000345,
PRIDE:PRD000376,
PRIDE:PRD000525,
PRIDE:PRD000526,
PRIDE:PRD000527,
PRIDE:PXD000013,
PRIDE:PXD000243,
PRIDE:PXD000252,
PRIDE:PXD000279,
PRIDE:PXD000396,
PRIDE:PXD000474,
PRIDE:PXD000589,
PRIDE:PXD000661,
PRIDE:PXD000680,
PRIDE:PXD000759,
PRIDE:PXD000883,
PRIDE:PXD000895,
PRIDE:PXD000900,
PRIDE:PXD000953,
PRIDE:PXD000954,
PRIDE:PXD000999,
PRIDE:PXD001047,
PRIDE:PXD001118,
PRIDE:PXD001154,
PRIDE:PXD001175,
PRIDE:PXD001249,
PRIDE:PXD001258,
PRIDE:PXD001259,
PRIDE:PXD001278,
PRIDE:PXD001305,
PRIDE:PXD001374,
PRIDE:PXD001381,
PRIDE:PXD001396,
PRIDE:PXD001441,
PRIDE:PXD001541,
PRIDE:PXD001548,
PRIDE:PXD001574,
PRIDE:PXD001660,
PRIDE:PXD001781,
PRIDE:PXD001798,
PRIDE:PXD001805,
PRIDE:PXD001806,
PRIDE:PXD001810,
PRIDE:PXD001863,
PRIDE:PXD001907,
PRIDE:PXD002001,
PRIDE:PXD002039,
PRIDE:PXD002066,
PRIDE:PXD002252,
PRIDE:PXD002277,
PRIDE:PXD002378,
PRIDE:PXD002383,
PRIDE:PXD002395,
PRIDE:PXD002572,
PRIDE:PXD002591,
PRIDE:PXD002704,
PRIDE:PXD002844,
PRIDE:PXD002880,
PRIDE:PXD003186,
PRIDE:PXD003209,
PRIDE:PXD003258,
PRIDE:PXD003370,
PRIDE:PXD003503,
PRIDE:PXD003530,
PRIDE:PXD003560,
PRIDE:PXD003792,
PRIDE:PXD003813,
PRIDE:PXD003909,
PRIDE:PXD003913,
PRIDE:PXD003917,
PRIDE:PXD003924,
PRIDE:PXD004182,
PRIDE:PXD004271,
PRIDE:PXD004273,
PRIDE:PXD004452,
PRIDE:PXD004613,
PRIDE:PXD004736,
PRIDE:PXD004900,
PRIDE:PXD004914,
PRIDE:PXD004933,
PRIDE:PXD004934,
PRIDE:PXD004940,
PRIDE:PXD004995,
PRIDE:PXD005018,
PRIDE:PXD005107,
PRIDE:PXD005181,
PRIDE:PXD005346,
PRIDE:PXD005349,
PRIDE:PXD005366,
PRIDE:PXD005466,
PRIDE:PXD005509,
PRIDE:PXD005572,
PRIDE:PXD005712,
PRIDE:PXD005955,
PRIDE:PXD006112,
PRIDE:PXD006293,
PRIDE:PXD012045,
PRIDE:PXD012188,
PRIDE:PXD013064,
PRIDE:PXD023271,
PRIDE:PXD023835,
PRIDE:PXD027504,
PRIDE:PXD029773,
PRIDE:PXD030304,
Progenetix:CVCL_0030,
PubChem_Cell_line:CVCL_0030,
RCB:RCB0007,
RCB:RCB3680,
SKY/M-FISH/CGH:5351,
TKG:TKG 0331,
TOKU-E:1434,
Ubigene:YC-A012,
Wikidata:Q847482 |
|
|
CVCL_0030 |
2026-07-25 04:40:43 |
39012 |
HeLa
Resource Report
Resource Website
10000+ mentions
Discontinued
|
CCTCC Cat# GDC0009, RRID:CVCL_0030
|
Homo sapiens (Human)
|
Human papillomavirus-related endocervical adenocarcinoma
|
Miscellaneous: HeLa is the most frequent contributor to cell lines contamination., Anecdotal: Was flown since the 1960s on at least ten different space missions: Korabl-Sputnik-2, Vostok-1, Vostok-4, Vostok-5 and Vostok-6, Voshkod 1 and Zond-5, Discoverer XVIII, Progress M-35/Mir and Shuttle STS-89., Anecdotal: The HeLa cell line and its story inspired Australian artist Cynthia Verspaget to embark in 2003 on a artistic project 'The Anarchy Cell Line' (TAnCL) where she mixed her blood with HeLa cells. This work later spawned a PhD thesis (CelloPub=CLPUB00376) where among other things she makes the observation that two main taxonomical distinctions present in the zombie, living/dead and human/nonhuman, are also present in the HeLa cell line., Anecdotal: The fascinating story of the HeLa cell line and of Henrietta Lacks from whom these cells originate are described in the book of Rebecca Skloot (CelloPub=CLPUB00377)., Anecdotal: The HeLa cell line which was established in February 1951 is the oldest human immortal cell line., Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Virology: HeLa has 5 five HPV18 integration sites: three on normal chromosomes 8 at 8q24 and two on derivative chromosomes, der(5)t(5;22;8)(q11;q11q13;q24) and der(22)t(8;22) (q24;q13)., Population: African American., Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982)., Part of: MD Anderson Cell Lines Project., Part of: Human Protein Atlas, Cell Atlas panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Space-flown cell line (cellonaut).
|
PMID:77569
PMID:1246620
PMID:1522048
PMID:2983228
PMID:2990217
PMID:3028716
PMID:3180844
PMID:3371749
PMID:3518877
PMID:4942173
PMID:5668122
PMID:6256643
PMID:6358339
PMID:6401685
PMID:6825208
PMID:6935474
PMID:8380785
PMID:9892199
PMID:10423141
PMID:11416159
PMID:11668190
PMID:12001993
PMID:12661003
PMID:12793746
PMID:13052828
PMID:13207312
PMID:13261081
PMID:14031339
PMID:14185313
PMID:15302935
PMID:15531914
PMID:15901131
PMID:16589695
PMID:16957166
PMID:17311676
PMID:19450234
PMID:19722756
PMID:19941903
PMID:21269460
PMID:21937730
PMID:22068331
PMID:22278370
PMID:22412903
PMID:23205564
PMID:23336012
PMID:23925224
PMID:23925245
PMID:24134916
PMID:24618588
PMID:24696503
PMID:24908793
PMID:25485619
PMID:25807930
PMID:25877200
PMID:25894527
PMID:25960936
PMID:26554430
PMID:26589293
PMID:27397505
PMID:28078501
PMID:28196595
PMID:28261610
PMID:28601559
PMID:29156801
PMID:30175587
PMID:30778230
PMID:30787054
PMID:30894373
PMID:31068700
PMID:31433507
PMID:31790455
PMID:33389257
PMID:35198691
PMID:35839778
PMID:37543987
|
Cancer cell line
|
Female |
HELA, Hela, He La, He-La, HeLa-CCL2, Henrietta Lacks cells, Helacyton gartleri |
CCTCC |
GDC0009 |
BTO:BTO_0000567,
CLO:CLO_0003684,
CLO:CLO_0050910,
EFO:EFO_0001185,
MCCL:MCC:0000219,
CLDB:cl1594,
CLDB:cl1595,
CLDB:cl1596,
CLDB:cl1597,
CLDB:cl1599,
CLDB:cl1600,
CLDB:cl1601,
CLDB:cl1603,
Abcam:ab255448,
Abcam:ab255928,
Abcam:ab260075,
Abcam:ab271142,
Abcam:ab275466,
AddexBio:C0008001/44,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-3610,
ATCC:CCL-2,
ATCC:CRL-7923,
ATCC:CRM-CCL-2,
BCRC:60005,
BCRJ:0100,
BEI_Resources:ARP-153,
BioGRID_ORCS_Cell_line:95,
BioSample:SAMN03471148,
BioSample:SAMN03472333,
BioSample:SAMN10989629,
cancercelllines:CVCL_0030,
CCLV:CCLV-RIE 0082,
CCRID:1101HUM-PUMC000011,
CCRID:1101HUM-PUMC000332,
CCRID:1102HUM-NIFDC00057,
CCRID:3101HUMSCSP504,
CCRID:3101HUMTCHu187,
CCRID:4201HUM-CCTCC00009,
CCRID:5301HUM-KCB90024YJ,
CCTCC:GDC0009,
Cell_Model_Passport:SIDM00846,
ChEMBL-Cells:CHEMBL3308376,
ChEMBL-Targets:CHEMBL399,
CLS:300194,
Cosmic:760219,
Cosmic:760490,
Cosmic:801357,
Cosmic:809231,
Cosmic:877477,
Cosmic:911999,
Cosmic:925354,
Cosmic:928907,
Cosmic:944113,
Cosmic:1019309,
Cosmic:1057766,
Cosmic:1071911,
Cosmic:1131525,
Cosmic:1193029,
Cosmic:1201779,
Cosmic:1324208,
Cosmic:1336880,
Cosmic:1571796,
Cosmic:2301539,
Cosmic:2660190,
Cosmic:2750874,
Cosmic:2791019,
Cosmic:2816214,
Cosmic-CLP:1298134,
dbGAP:phs000640.v4.p1,
DepMap:ACH-001086,
DSMZ:ACC-57,
DSMZCellDive:ACC-57,
ECACC:93021013,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
EGA:phs000640,
FCS-free:44-2-47-1-8-9,
GDSC:1298134,
GEO:GSM113863,
GEO:GSM226739,
GEO:GSM226875,
GEO:GSM253298,
GEO:GSM436128,
GEO:GSM436129,
GEO:GSM501788,
GEO:GSM722574,
GEO:GSM722575,
GEO:GSM723055,
GEO:GSM723056,
GEO:GSM1088663,
GEO:GSM1088664,
GEO:GSM1088665,
GEO:GSM1088666,
GEO:GSM1374528,
GEO:GSM1669875,
GEO:GSM1881473,
GEO:GSM1881474,
GEO:GSM1881475,
GEO:GSM7701367,
GEO:GSM7701368,
Hysigen:TCH-C193,
ICLC:HTL95023,
IGRhCellID:HeLA,
IZSLER:BS TCL 20,
JCRB:JCRB9004,
KCB:KCB 86019YJ,
KCB:KCB 90024YJ,
KCLB:10002,
LINCS_HMS:50061,
LINCS_LDP:LCL-1512,
Lonza:51,
MeSH:D006367,
NCBI_Iran:C115,
PharmacoDB:HeLa_536_2019,
PRIDE:PRD000007,
PRIDE:PRD000032,
PRIDE:PRD000123,
PRIDE:PRD000124,
PRIDE:PRD000345,
PRIDE:PRD000376,
PRIDE:PRD000525,
PRIDE:PRD000526,
PRIDE:PRD000527,
PRIDE:PXD000013,
PRIDE:PXD000243,
PRIDE:PXD000252,
PRIDE:PXD000279,
PRIDE:PXD000396,
PRIDE:PXD000474,
PRIDE:PXD000589,
PRIDE:PXD000661,
PRIDE:PXD000680,
PRIDE:PXD000759,
PRIDE:PXD000883,
PRIDE:PXD000895,
PRIDE:PXD000900,
PRIDE:PXD000953,
PRIDE:PXD000954,
PRIDE:PXD000999,
PRIDE:PXD001047,
PRIDE:PXD001118,
PRIDE:PXD001154,
PRIDE:PXD001175,
PRIDE:PXD001249,
PRIDE:PXD001258,
PRIDE:PXD001259,
PRIDE:PXD001278,
PRIDE:PXD001305,
PRIDE:PXD001374,
PRIDE:PXD001381,
PRIDE:PXD001396,
PRIDE:PXD001441,
PRIDE:PXD001541,
PRIDE:PXD001548,
PRIDE:PXD001574,
PRIDE:PXD001660,
PRIDE:PXD001781,
PRIDE:PXD001798,
PRIDE:PXD001805,
PRIDE:PXD001806,
PRIDE:PXD001810,
PRIDE:PXD001863,
PRIDE:PXD001907,
PRIDE:PXD002001,
PRIDE:PXD002039,
PRIDE:PXD002066,
PRIDE:PXD002252,
PRIDE:PXD002277,
PRIDE:PXD002378,
PRIDE:PXD002383,
PRIDE:PXD002395,
PRIDE:PXD002572,
PRIDE:PXD002591,
PRIDE:PXD002704,
PRIDE:PXD002844,
PRIDE:PXD002880,
PRIDE:PXD003186,
PRIDE:PXD003209,
PRIDE:PXD003258,
PRIDE:PXD003370,
PRIDE:PXD003503,
PRIDE:PXD003530,
PRIDE:PXD003560,
PRIDE:PXD003792,
PRIDE:PXD003813,
PRIDE:PXD003909,
PRIDE:PXD003913,
PRIDE:PXD003917,
PRIDE:PXD003924,
PRIDE:PXD004182,
PRIDE:PXD004271,
PRIDE:PXD004273,
PRIDE:PXD004452,
PRIDE:PXD004613,
PRIDE:PXD004736,
PRIDE:PXD004900,
PRIDE:PXD004914,
PRIDE:PXD004933,
PRIDE:PXD004934,
PRIDE:PXD004940,
PRIDE:PXD004995,
PRIDE:PXD005018,
PRIDE:PXD005107,
PRIDE:PXD005181,
PRIDE:PXD005346,
PRIDE:PXD005349,
PRIDE:PXD005366,
PRIDE:PXD005466,
PRIDE:PXD005509,
PRIDE:PXD005572,
PRIDE:PXD005712,
PRIDE:PXD005955,
PRIDE:PXD006112,
PRIDE:PXD006293,
PRIDE:PXD012045,
PRIDE:PXD012188,
PRIDE:PXD013064,
PRIDE:PXD023271,
PRIDE:PXD023835,
PRIDE:PXD027504,
PRIDE:PXD029773,
PRIDE:PXD030304,
Progenetix:CVCL_0030,
PubChem_Cell_line:CVCL_0030,
RCB:RCB0007,
RCB:RCB3680,
SKY/M-FISH/CGH:5351,
TKG:TKG 0331,
TOKU-E:1434,
Ubigene:YC-A012,
Wikidata:Q847482 |
|
|
CVCL_0030 |
2026-07-25 04:40:43 |
39012 |
HeLa
Resource Report
Resource Website
10000+ mentions
Discontinued
|
NCBI_Iran Cat# C115, RRID:CVCL_0030
|
Homo sapiens (Human)
|
Human papillomavirus-related endocervical adenocarcinoma
|
Miscellaneous: HeLa is the most frequent contributor to cell lines contamination., Anecdotal: Was flown since the 1960s on at least ten different space missions: Korabl-Sputnik-2, Vostok-1, Vostok-4, Vostok-5 and Vostok-6, Voshkod 1 and Zond-5, Discoverer XVIII, Progress M-35/Mir and Shuttle STS-89., Anecdotal: The HeLa cell line and its story inspired Australian artist Cynthia Verspaget to embark in 2003 on a artistic project 'The Anarchy Cell Line' (TAnCL) where she mixed her blood with HeLa cells. This work later spawned a PhD thesis (CelloPub=CLPUB00376) where among other things she makes the observation that two main taxonomical distinctions present in the zombie, living/dead and human/nonhuman, are also present in the HeLa cell line., Anecdotal: The fascinating story of the HeLa cell line and of Henrietta Lacks from whom these cells originate are described in the book of Rebecca Skloot (CelloPub=CLPUB00377)., Anecdotal: The HeLa cell line which was established in February 1951 is the oldest human immortal cell line., Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Virology: HeLa has 5 five HPV18 integration sites: three on normal chromosomes 8 at 8q24 and two on derivative chromosomes, der(5)t(5;22;8)(q11;q11q13;q24) and der(22)t(8;22) (q24;q13)., Population: African American., Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982)., Part of: MD Anderson Cell Lines Project., Part of: Human Protein Atlas, Cell Atlas panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Space-flown cell line (cellonaut).
|
PMID:77569
PMID:1246620
PMID:1522048
PMID:2983228
PMID:2990217
PMID:3028716
PMID:3180844
PMID:3371749
PMID:3518877
PMID:4942173
PMID:5668122
PMID:6256643
PMID:6358339
PMID:6401685
PMID:6825208
PMID:6935474
PMID:8380785
PMID:9892199
PMID:10423141
PMID:11416159
PMID:11668190
PMID:12001993
PMID:12661003
PMID:12793746
PMID:13052828
PMID:13207312
PMID:13261081
PMID:14031339
PMID:14185313
PMID:15302935
PMID:15531914
PMID:15901131
PMID:16589695
PMID:16957166
PMID:17311676
PMID:19450234
PMID:19722756
PMID:19941903
PMID:21269460
PMID:21937730
PMID:22068331
PMID:22278370
PMID:22412903
PMID:23205564
PMID:23336012
PMID:23925224
PMID:23925245
PMID:24134916
PMID:24618588
PMID:24696503
PMID:24908793
PMID:25485619
PMID:25807930
PMID:25877200
PMID:25894527
PMID:25960936
PMID:26554430
PMID:26589293
PMID:27397505
PMID:28078501
PMID:28196595
PMID:28261610
PMID:28601559
PMID:29156801
PMID:30175587
PMID:30778230
PMID:30787054
PMID:30894373
PMID:31068700
PMID:31433507
PMID:31790455
PMID:33389257
PMID:35198691
PMID:35839778
PMID:37543987
|
Cancer cell line
|
Female |
HELA, Hela, He La, He-La, HeLa-CCL2, Henrietta Lacks cells, Helacyton gartleri |
NCBI_Iran |
C115 |
BTO:BTO_0000567,
CLO:CLO_0003684,
CLO:CLO_0050910,
EFO:EFO_0001185,
MCCL:MCC:0000219,
CLDB:cl1594,
CLDB:cl1595,
CLDB:cl1596,
CLDB:cl1597,
CLDB:cl1599,
CLDB:cl1600,
CLDB:cl1601,
CLDB:cl1603,
Abcam:ab255448,
Abcam:ab255928,
Abcam:ab260075,
Abcam:ab271142,
Abcam:ab275466,
AddexBio:C0008001/44,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-3610,
ATCC:CCL-2,
ATCC:CRL-7923,
ATCC:CRM-CCL-2,
BCRC:60005,
BCRJ:0100,
BEI_Resources:ARP-153,
BioGRID_ORCS_Cell_line:95,
BioSample:SAMN03471148,
BioSample:SAMN03472333,
BioSample:SAMN10989629,
cancercelllines:CVCL_0030,
CCLV:CCLV-RIE 0082,
CCRID:1101HUM-PUMC000011,
CCRID:1101HUM-PUMC000332,
CCRID:1102HUM-NIFDC00057,
CCRID:3101HUMSCSP504,
CCRID:3101HUMTCHu187,
CCRID:4201HUM-CCTCC00009,
CCRID:5301HUM-KCB90024YJ,
CCTCC:GDC0009,
Cell_Model_Passport:SIDM00846,
ChEMBL-Cells:CHEMBL3308376,
ChEMBL-Targets:CHEMBL399,
CLS:300194,
Cosmic:760219,
Cosmic:760490,
Cosmic:801357,
Cosmic:809231,
Cosmic:877477,
Cosmic:911999,
Cosmic:925354,
Cosmic:928907,
Cosmic:944113,
Cosmic:1019309,
Cosmic:1057766,
Cosmic:1071911,
Cosmic:1131525,
Cosmic:1193029,
Cosmic:1201779,
Cosmic:1324208,
Cosmic:1336880,
Cosmic:1571796,
Cosmic:2301539,
Cosmic:2660190,
Cosmic:2750874,
Cosmic:2791019,
Cosmic:2816214,
Cosmic-CLP:1298134,
dbGAP:phs000640.v4.p1,
DepMap:ACH-001086,
DSMZ:ACC-57,
DSMZCellDive:ACC-57,
ECACC:93021013,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
EGA:phs000640,
FCS-free:44-2-47-1-8-9,
GDSC:1298134,
GEO:GSM113863,
GEO:GSM226739,
GEO:GSM226875,
GEO:GSM253298,
GEO:GSM436128,
GEO:GSM436129,
GEO:GSM501788,
GEO:GSM722574,
GEO:GSM722575,
GEO:GSM723055,
GEO:GSM723056,
GEO:GSM1088663,
GEO:GSM1088664,
GEO:GSM1088665,
GEO:GSM1088666,
GEO:GSM1374528,
GEO:GSM1669875,
GEO:GSM1881473,
GEO:GSM1881474,
GEO:GSM1881475,
GEO:GSM7701367,
GEO:GSM7701368,
Hysigen:TCH-C193,
ICLC:HTL95023,
IGRhCellID:HeLA,
IZSLER:BS TCL 20,
JCRB:JCRB9004,
KCB:KCB 86019YJ,
KCB:KCB 90024YJ,
KCLB:10002,
LINCS_HMS:50061,
LINCS_LDP:LCL-1512,
Lonza:51,
MeSH:D006367,
NCBI_Iran:C115,
PharmacoDB:HeLa_536_2019,
PRIDE:PRD000007,
PRIDE:PRD000032,
PRIDE:PRD000123,
PRIDE:PRD000124,
PRIDE:PRD000345,
PRIDE:PRD000376,
PRIDE:PRD000525,
PRIDE:PRD000526,
PRIDE:PRD000527,
PRIDE:PXD000013,
PRIDE:PXD000243,
PRIDE:PXD000252,
PRIDE:PXD000279,
PRIDE:PXD000396,
PRIDE:PXD000474,
PRIDE:PXD000589,
PRIDE:PXD000661,
PRIDE:PXD000680,
PRIDE:PXD000759,
PRIDE:PXD000883,
PRIDE:PXD000895,
PRIDE:PXD000900,
PRIDE:PXD000953,
PRIDE:PXD000954,
PRIDE:PXD000999,
PRIDE:PXD001047,
PRIDE:PXD001118,
PRIDE:PXD001154,
PRIDE:PXD001175,
PRIDE:PXD001249,
PRIDE:PXD001258,
PRIDE:PXD001259,
PRIDE:PXD001278,
PRIDE:PXD001305,
PRIDE:PXD001374,
PRIDE:PXD001381,
PRIDE:PXD001396,
PRIDE:PXD001441,
PRIDE:PXD001541,
PRIDE:PXD001548,
PRIDE:PXD001574,
PRIDE:PXD001660,
PRIDE:PXD001781,
PRIDE:PXD001798,
PRIDE:PXD001805,
PRIDE:PXD001806,
PRIDE:PXD001810,
PRIDE:PXD001863,
PRIDE:PXD001907,
PRIDE:PXD002001,
PRIDE:PXD002039,
PRIDE:PXD002066,
PRIDE:PXD002252,
PRIDE:PXD002277,
PRIDE:PXD002378,
PRIDE:PXD002383,
PRIDE:PXD002395,
PRIDE:PXD002572,
PRIDE:PXD002591,
PRIDE:PXD002704,
PRIDE:PXD002844,
PRIDE:PXD002880,
PRIDE:PXD003186,
PRIDE:PXD003209,
PRIDE:PXD003258,
PRIDE:PXD003370,
PRIDE:PXD003503,
PRIDE:PXD003530,
PRIDE:PXD003560,
PRIDE:PXD003792,
PRIDE:PXD003813,
PRIDE:PXD003909,
PRIDE:PXD003913,
PRIDE:PXD003917,
PRIDE:PXD003924,
PRIDE:PXD004182,
PRIDE:PXD004271,
PRIDE:PXD004273,
PRIDE:PXD004452,
PRIDE:PXD004613,
PRIDE:PXD004736,
PRIDE:PXD004900,
PRIDE:PXD004914,
PRIDE:PXD004933,
PRIDE:PXD004934,
PRIDE:PXD004940,
PRIDE:PXD004995,
PRIDE:PXD005018,
PRIDE:PXD005107,
PRIDE:PXD005181,
PRIDE:PXD005346,
PRIDE:PXD005349,
PRIDE:PXD005366,
PRIDE:PXD005466,
PRIDE:PXD005509,
PRIDE:PXD005572,
PRIDE:PXD005712,
PRIDE:PXD005955,
PRIDE:PXD006112,
PRIDE:PXD006293,
PRIDE:PXD012045,
PRIDE:PXD012188,
PRIDE:PXD013064,
PRIDE:PXD023271,
PRIDE:PXD023835,
PRIDE:PXD027504,
PRIDE:PXD029773,
PRIDE:PXD030304,
Progenetix:CVCL_0030,
PubChem_Cell_line:CVCL_0030,
RCB:RCB0007,
RCB:RCB3680,
SKY/M-FISH/CGH:5351,
TKG:TKG 0331,
TOKU-E:1434,
Ubigene:YC-A012,
Wikidata:Q847482 |
|
|
CVCL_0030 |
2026-07-25 04:40:44 |
39012 |
HeLa
Resource Report
Resource Website
10000+ mentions
Discontinued
|
DSMZ Cat# ACC-57, RRID:CVCL_0030
|
Homo sapiens (Human)
|
Human papillomavirus-related endocervical adenocarcinoma
|
Miscellaneous: HeLa is the most frequent contributor to cell lines contamination., Anecdotal: Was flown since the 1960s on at least ten different space missions: Korabl-Sputnik-2, Vostok-1, Vostok-4, Vostok-5 and Vostok-6, Voshkod 1 and Zond-5, Discoverer XVIII, Progress M-35/Mir and Shuttle STS-89., Anecdotal: The HeLa cell line and its story inspired Australian artist Cynthia Verspaget to embark in 2003 on a artistic project 'The Anarchy Cell Line' (TAnCL) where she mixed her blood with HeLa cells. This work later spawned a PhD thesis (CelloPub=CLPUB00376) where among other things she makes the observation that two main taxonomical distinctions present in the zombie, living/dead and human/nonhuman, are also present in the HeLa cell line., Anecdotal: The fascinating story of the HeLa cell line and of Henrietta Lacks from whom these cells originate are described in the book of Rebecca Skloot (CelloPub=CLPUB00377)., Anecdotal: The HeLa cell line which was established in February 1951 is the oldest human immortal cell line., Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Virology: HeLa has 5 five HPV18 integration sites: three on normal chromosomes 8 at 8q24 and two on derivative chromosomes, der(5)t(5;22;8)(q11;q11q13;q24) and der(22)t(8;22) (q24;q13)., Population: African American., Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982)., Part of: MD Anderson Cell Lines Project., Part of: Human Protein Atlas, Cell Atlas panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Space-flown cell line (cellonaut).
|
PMID:77569
PMID:1246620
PMID:1522048
PMID:2983228
PMID:2990217
PMID:3028716
PMID:3180844
PMID:3371749
PMID:3518877
PMID:4942173
PMID:5668122
PMID:6256643
PMID:6358339
PMID:6401685
PMID:6825208
PMID:6935474
PMID:8380785
PMID:9892199
PMID:10423141
PMID:11416159
PMID:11668190
PMID:12001993
PMID:12661003
PMID:12793746
PMID:13052828
PMID:13207312
PMID:13261081
PMID:14031339
PMID:14185313
PMID:15302935
PMID:15531914
PMID:15901131
PMID:16589695
PMID:16957166
PMID:17311676
PMID:19450234
PMID:19722756
PMID:19941903
PMID:21269460
PMID:21937730
PMID:22068331
PMID:22278370
PMID:22412903
PMID:23205564
PMID:23336012
PMID:23925224
PMID:23925245
PMID:24134916
PMID:24618588
PMID:24696503
PMID:24908793
PMID:25485619
PMID:25807930
PMID:25877200
PMID:25894527
PMID:25960936
PMID:26554430
PMID:26589293
PMID:27397505
PMID:28078501
PMID:28196595
PMID:28261610
PMID:28601559
PMID:29156801
PMID:30175587
PMID:30778230
PMID:30787054
PMID:30894373
PMID:31068700
PMID:31433507
PMID:31790455
PMID:33389257
PMID:35198691
PMID:35839778
PMID:37543987
|
Cancer cell line
|
Female |
HELA, Hela, He La, He-La, HeLa-CCL2, Henrietta Lacks cells, Helacyton gartleri |
DSMZ |
ACC-57 |
BTO:BTO_0000567,
CLO:CLO_0003684,
CLO:CLO_0050910,
EFO:EFO_0001185,
MCCL:MCC:0000219,
CLDB:cl1594,
CLDB:cl1595,
CLDB:cl1596,
CLDB:cl1597,
CLDB:cl1599,
CLDB:cl1600,
CLDB:cl1601,
CLDB:cl1603,
Abcam:ab255448,
Abcam:ab255928,
Abcam:ab260075,
Abcam:ab271142,
Abcam:ab275466,
AddexBio:C0008001/44,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-3610,
ATCC:CCL-2,
ATCC:CRL-7923,
ATCC:CRM-CCL-2,
BCRC:60005,
BCRJ:0100,
BEI_Resources:ARP-153,
BioGRID_ORCS_Cell_line:95,
BioSample:SAMN03471148,
BioSample:SAMN03472333,
BioSample:SAMN10989629,
cancercelllines:CVCL_0030,
CCLV:CCLV-RIE 0082,
CCRID:1101HUM-PUMC000011,
CCRID:1101HUM-PUMC000332,
CCRID:1102HUM-NIFDC00057,
CCRID:3101HUMSCSP504,
CCRID:3101HUMTCHu187,
CCRID:4201HUM-CCTCC00009,
CCRID:5301HUM-KCB90024YJ,
CCTCC:GDC0009,
Cell_Model_Passport:SIDM00846,
ChEMBL-Cells:CHEMBL3308376,
ChEMBL-Targets:CHEMBL399,
CLS:300194,
Cosmic:760219,
Cosmic:760490,
Cosmic:801357,
Cosmic:809231,
Cosmic:877477,
Cosmic:911999,
Cosmic:925354,
Cosmic:928907,
Cosmic:944113,
Cosmic:1019309,
Cosmic:1057766,
Cosmic:1071911,
Cosmic:1131525,
Cosmic:1193029,
Cosmic:1201779,
Cosmic:1324208,
Cosmic:1336880,
Cosmic:1571796,
Cosmic:2301539,
Cosmic:2660190,
Cosmic:2750874,
Cosmic:2791019,
Cosmic:2816214,
Cosmic-CLP:1298134,
dbGAP:phs000640.v4.p1,
DepMap:ACH-001086,
DSMZ:ACC-57,
DSMZCellDive:ACC-57,
ECACC:93021013,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
EGA:phs000640,
FCS-free:44-2-47-1-8-9,
GDSC:1298134,
GEO:GSM113863,
GEO:GSM226739,
GEO:GSM226875,
GEO:GSM253298,
GEO:GSM436128,
GEO:GSM436129,
GEO:GSM501788,
GEO:GSM722574,
GEO:GSM722575,
GEO:GSM723055,
GEO:GSM723056,
GEO:GSM1088663,
GEO:GSM1088664,
GEO:GSM1088665,
GEO:GSM1088666,
GEO:GSM1374528,
GEO:GSM1669875,
GEO:GSM1881473,
GEO:GSM1881474,
GEO:GSM1881475,
GEO:GSM7701367,
GEO:GSM7701368,
Hysigen:TCH-C193,
ICLC:HTL95023,
IGRhCellID:HeLA,
IZSLER:BS TCL 20,
JCRB:JCRB9004,
KCB:KCB 86019YJ,
KCB:KCB 90024YJ,
KCLB:10002,
LINCS_HMS:50061,
LINCS_LDP:LCL-1512,
Lonza:51,
MeSH:D006367,
NCBI_Iran:C115,
PharmacoDB:HeLa_536_2019,
PRIDE:PRD000007,
PRIDE:PRD000032,
PRIDE:PRD000123,
PRIDE:PRD000124,
PRIDE:PRD000345,
PRIDE:PRD000376,
PRIDE:PRD000525,
PRIDE:PRD000526,
PRIDE:PRD000527,
PRIDE:PXD000013,
PRIDE:PXD000243,
PRIDE:PXD000252,
PRIDE:PXD000279,
PRIDE:PXD000396,
PRIDE:PXD000474,
PRIDE:PXD000589,
PRIDE:PXD000661,
PRIDE:PXD000680,
PRIDE:PXD000759,
PRIDE:PXD000883,
PRIDE:PXD000895,
PRIDE:PXD000900,
PRIDE:PXD000953,
PRIDE:PXD000954,
PRIDE:PXD000999,
PRIDE:PXD001047,
PRIDE:PXD001118,
PRIDE:PXD001154,
PRIDE:PXD001175,
PRIDE:PXD001249,
PRIDE:PXD001258,
PRIDE:PXD001259,
PRIDE:PXD001278,
PRIDE:PXD001305,
PRIDE:PXD001374,
PRIDE:PXD001381,
PRIDE:PXD001396,
PRIDE:PXD001441,
PRIDE:PXD001541,
PRIDE:PXD001548,
PRIDE:PXD001574,
PRIDE:PXD001660,
PRIDE:PXD001781,
PRIDE:PXD001798,
PRIDE:PXD001805,
PRIDE:PXD001806,
PRIDE:PXD001810,
PRIDE:PXD001863,
PRIDE:PXD001907,
PRIDE:PXD002001,
PRIDE:PXD002039,
PRIDE:PXD002066,
PRIDE:PXD002252,
PRIDE:PXD002277,
PRIDE:PXD002378,
PRIDE:PXD002383,
PRIDE:PXD002395,
PRIDE:PXD002572,
PRIDE:PXD002591,
PRIDE:PXD002704,
PRIDE:PXD002844,
PRIDE:PXD002880,
PRIDE:PXD003186,
PRIDE:PXD003209,
PRIDE:PXD003258,
PRIDE:PXD003370,
PRIDE:PXD003503,
PRIDE:PXD003530,
PRIDE:PXD003560,
PRIDE:PXD003792,
PRIDE:PXD003813,
PRIDE:PXD003909,
PRIDE:PXD003913,
PRIDE:PXD003917,
PRIDE:PXD003924,
PRIDE:PXD004182,
PRIDE:PXD004271,
PRIDE:PXD004273,
PRIDE:PXD004452,
PRIDE:PXD004613,
PRIDE:PXD004736,
PRIDE:PXD004900,
PRIDE:PXD004914,
PRIDE:PXD004933,
PRIDE:PXD004934,
PRIDE:PXD004940,
PRIDE:PXD004995,
PRIDE:PXD005018,
PRIDE:PXD005107,
PRIDE:PXD005181,
PRIDE:PXD005346,
PRIDE:PXD005349,
PRIDE:PXD005366,
PRIDE:PXD005466,
PRIDE:PXD005509,
PRIDE:PXD005572,
PRIDE:PXD005712,
PRIDE:PXD005955,
PRIDE:PXD006112,
PRIDE:PXD006293,
PRIDE:PXD012045,
PRIDE:PXD012188,
PRIDE:PXD013064,
PRIDE:PXD023271,
PRIDE:PXD023835,
PRIDE:PXD027504,
PRIDE:PXD029773,
PRIDE:PXD030304,
Progenetix:CVCL_0030,
PubChem_Cell_line:CVCL_0030,
RCB:RCB0007,
RCB:RCB3680,
SKY/M-FISH/CGH:5351,
TKG:TKG 0331,
TOKU-E:1434,
Ubigene:YC-A012,
Wikidata:Q847482 |
|
|
CVCL_0030 |
2026-07-25 04:40:44 |
39012 |
Hep 3B2.1-7
Resource Report
Resource Website
1000+ mentions
Discontinued
|
RRID:CVCL_0326
|
Homo sapiens (Human)
|
Childhood hepatocellular carcinoma
|
Karyotypic information: Has lost chromosome Y., Population: African American., Part of: TCGA-110-CL cell line panel., Part of: MD Anderson Cell Lines Project., Part of: Liver Cancer Model Repository (LIMORE)., Part of: JFCR45 cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Patented cell line.
|
PMID:233137
PMID:2439335
PMID:3023526
PMID:3431441
PMID:6248960
PMID:6275024
PMID:6288577
PMID:7972006
PMID:8050184
PMID:8224613
PMID:8389256
PMID:8835345
PMID:9290701
PMID:9359923
PMID:10523694
PMID:11050057
PMID:12029633
PMID:15767549
PMID:20215515
PMID:20454443
PMID:20937217
PMID:22460905
PMID:23505090
PMID:23887712
PMID:24116068
PMID:25574106
PMID:25877200
PMID:27397505
PMID:28196595
PMID:29610054
PMID:30629668
PMID:30894373
PMID:31063779
PMID:31068700
PMID:31378681
PMID:31395879
PMID:31978347
PMID:32899426
PMID:34320349
PMID:35839778
|
Cancer cell line
|
Male |
Hep 3B2_1-7, Hep 3B 2.1-7, HEP3B217, Hep 3B2, HEP-3B2, HEP3B2, Hep-3B, HEP-3B, Hep 3B, Hep3B, HEP3B |
|
|
BTO:BTO_0000972,
CLO:CLO_0003702,
CLO:CLO_0003703,
CLO:CLO_0003710,
EFO:EFO_0002205,
MCCL:MCC:0000221,
CLDB:cl1627,
CLDB:cl1628,
CLDB:cl1629,
CLDB:cl1630,
AddexBio:C0015001/45,
ArrayExpress:E-MTAB-38,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
ATCC:HB-8064,
BCRC:60434,
BCRJ:0357,
BioGRID_ORCS_Cell_line:810,
BioSample:SAMN03473193,
BioSample:SAMN10988098,
cancercelllines:CVCL_0326,
CCRID:1101HUM-PUMC000376,
CCRID:1101HUM-PUMC000474,
CCRID:1102HUM-NIFDC00059,
CCRID:3101HUMSCSP5045,
CCRID:3101HUMTCHu106,
CCRID:4201HUM-CCTCC00070,
CCTCC:GDC0070,
Cell_Model_Passport:SIDM00672,
CGH-DB:454-3,
CGH-DB:9069-4,
ChEMBL-Cells:CHEMBL4106361,
ChEMBL-Targets:CHEMBL4296437,
CLS:305141,
Cosmic:873401,
Cosmic:928140,
Cosmic:934549,
Cosmic:948066,
Cosmic:979729,
Cosmic:999851,
Cosmic:1019316,
Cosmic:1177682,
Cosmic:1351510,
Cosmic:1518225,
Cosmic:1628385,
Cosmic:2023864,
Cosmic:2162536,
Cosmic:2301557,
Cosmic:2321030,
Cosmic:2668282,
Cosmic:2773181,
Cosmic:2816904,
Cosmic-CLP:1240147,
DepMap:ACH-000625,
DSMZ:ACC-93,
DSMZCellDive:ACC-93,
ECACC:86062703,
EGA:EGAS00001000978,
GDSC:1240147,
GEO:GSM207050,
GEO:GSM501778,
GEO:GSM565879,
GEO:GSM887078,
GEO:GSM888148,
GEO:GSM936759,
GEO:GSM1374531,
GEO:GSM1669879,
GEO:GSM2551564,
Hysigen:TCH-C195,
IARC_TP53:30036,
IGRhCellID:Hep3B,
IZSLER:BS TCL 78,
KCB:KCB 200771YJ,
KCB:KCB 200942YJ,
KCLB:88064,
LiGeA:CCLE_655,
LIMORE:Hep3B,
LINCS_LDP:LCL-1924,
Lonza:473,
PharmacoDB:Hep3B2_17_538_2019,
PRIDE:PXD000533,
PRIDE:PXD000535,
PRIDE:PXD005291,
PRIDE:PXD008190,
PRIDE:PXD030304,
Progenetix:CVCL_0326,
PubChem_Cell_line:CVCL_0326,
RCB:RCB2090,
TKG:TKG 0291,
TOKU-E:1439,
TOKU-E:3574,
Ubigene:YC-D002,
Wikidata:Q54882746 |
|
|
CVCL_0326 |
2026-07-25 04:40:49 |
3979 |
KLE
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_1329
|
Homo sapiens (Human)
|
Type II endometrial adenocarcinoma
|
Population: Caucasian., Part of: TCGA-110-CL cell line panel., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Part of: AKT genetic alteration cell panel (ATCC TCP-1029).
|
PMID:1541432
PMID:2436984
PMID:6706226
PMID:7798295
PMID:8123477
PMID:9887230
PMID:12893190
PMID:20164919
PMID:20215515
PMID:22460905
PMID:22710073
PMID:25485619
PMID:25877200
PMID:26589293
PMID:27397505
PMID:28196595
PMID:30894373
PMID:30971826
PMID:31068700
PMID:31395879
PMID:33174010
PMID:35839778
|
Cancer cell line
|
Female |
|
|
|
BTO:BTO_0005079,
CLO:CLO_0007104,
EFO:EFO_0002220,
ArrayExpress:E-MTAB-38,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
ATCC:CRL-1622,
BCRJ:0365,
BioGRID_ORCS_Cell_line:622,
BioSample:SAMN03473101,
BioSample:SAMN10987617,
cancercelllines:CVCL_1329,
CCRID:1101HUM-PUMC000379,
CCRID:4201HUM-CCTCC00115,
CCTCC:GDC0115,
Cell_Model_Passport:SIDM00686,
ChEMBL-Cells:CHEMBL3308518,
ChEMBL-Targets:CHEMBL2366239,
CLS:305051,
Cosmic:713476,
Cosmic:713493,
Cosmic:809133,
Cosmic:846179,
Cosmic:871554,
Cosmic:889114,
Cosmic:924187,
Cosmic:980636,
Cosmic:1007161,
Cosmic:1066225,
Cosmic:1070809,
Cosmic:1177622,
Cosmic:1223485,
Cosmic:1241349,
Cosmic:1576461,
Cosmic:1622900,
Cosmic:1696759,
Cosmic:2030477,
Cosmic:2646620,
Cosmic:2702442,
Cosmic-CLP:924187,
DepMap:ACH-000293,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
GDSC:924187,
GEO:GSM374973,
GEO:GSM375432,
GEO:GSM844574,
GEO:GSM844575,
GEO:GSM887211,
GEO:GSM888284,
GEO:GSM1669987,
GEO:GSM3161718,
GEO:GSM3161719,
IARC_TP53:1113,
IGRhCellID:KLE,
IZSLER:BS TCL 230,
LiGeA:CCLE_909,
LINCS_LDP:LCL-1505,
PharmacoDB:KLE_750_2019,
PRIDE:PXD030304,
Progenetix:CVCL_1329,
PubChem_Cell_line:CVCL_1329,
Wikidata:Q54900024 |
|
|
CVCL_1329 |
2026-07-25 04:47:44 |
17 |
KM-H2
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1330
|
Homo sapiens (Human)
|
Hodgkin lymphoma
|
Population: Japanese., Part of: MD Anderson Cell Lines Project., Part of: LL-100 blood cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2602653
PMID:2690233
PMID:3013343
PMID:3359046
PMID:8547074
PMID:8558920
PMID:11372738
PMID:17065008
PMID:18194364
PMID:19380639
PMID:20164919
PMID:20628145
PMID:21368758
PMID:22460905
PMID:25355872
PMID:25894527
PMID:26589293
PMID:27397505
PMID:28196595
PMID:29533902
PMID:30285677
PMID:30629668
PMID:30894373
PMID:31068700
PMID:31160637
PMID:35839778
|
Cancer cell line
|
Male |
KM H-2, KMH2 |
|
|
BTO:BTO_0004972,
CLO:CLO_0007112,
CLDB:cl3033,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
ArrayExpress:E-MTAB-7721,
ArrayExpress:E-MTAB-7722,
BioSample:SAMN03473401,
BioSample:SAMN10988578,
cancercelllines:CVCL_1330,
Cell_Model_Passport:SIDM01018,
ChEMBL-Cells:CHEMBL3308204,
ChEMBL-Targets:CHEMBL2366250,
Cosmic:909976,
Cosmic:988704,
Cosmic:1013910,
Cosmic:1086357,
Cosmic:1191707,
Cosmic:1289700,
Cosmic:1290219,
Cosmic:1432041,
Cosmic:2276325,
Cosmic:2361388,
Cosmic:2464308,
Cosmic-CLP:909976,
DepMap:ACH-000815,
DSMZ:ACC-8,
DSMZCellDive:ACC-8,
EGA:EGAS00001000978,
GDSC:909976,
GEO:GSM335391,
GEO:GSM499723,
GEO:GSM499731,
GEO:GSM552446,
GEO:GSM637987,
GEO:GSM646533,
GEO:GSM887214,
GEO:GSM888288,
GEO:GSM1669990,
IARC_TP53:21433,
IARC_TP53:23616,
IPD-IMGT/HLA:15116,
LiGeA:CCLE_432,
LINCS_LDP:LCL-2009,
Lonza:21,
PharmacoDB:KMH2_752_2019,
PRIDE:PXD000589,
PRIDE:PXD030304,
Progenetix:CVCL_1330,
PubChem_Cell_line:CVCL_1330,
Wikidata:Q54900048 |
|
|
CVCL_1330 |
2026-07-25 04:47:45 |
5 |
KM12
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1331
|
Homo sapiens (Human)
|
Colon carcinoma
|
Population: Caucasian., Part of: NCI-60 cancer cell line panel., Part of: MD Anderson Cell Lines Project., Part of: JFCR39 cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2041050
PMID:9331090
PMID:9515795
PMID:10700174
PMID:11416159
PMID:12615714
PMID:15748285
PMID:15900046
PMID:17088437
PMID:19372543
PMID:20164919
PMID:20570890
PMID:22068913
PMID:22336246
PMID:22347499
PMID:22384151
PMID:22460905
PMID:22628656
PMID:23856246
PMID:23933261
PMID:24279929
PMID:24670534
PMID:24755471
PMID:24962792
PMID:25485619
PMID:25877200
PMID:25926053
PMID:25944804
PMID:25984343
PMID:26537799
PMID:26589293
PMID:27377824
PMID:27397505
PMID:27807467
PMID:28179481
PMID:28196595
PMID:28683746
PMID:28854368
PMID:29444439
PMID:30894373
PMID:30971826
PMID:31068700
PMID:31733513
PMID:35839778
PMID:38861359
|
Cancer cell line
|
Male |
KM-12, KM.12 |
|
|
BTO:BTO_0003172,
CLO:CLO_0009965,
EFO:EFO_0006282,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
BioGRID_ORCS_Cell_line:412,
BioSample:SAMN03471909,
BioSample:SAMN10988369,
cancercelllines:CVCL_1331,
Cell_Model_Passport:SIDM00150,
ChEMBL-Cells:CHEMBL3307689,
ChEMBL-Targets:CHEMBL614709,
ColonAtlas:KM12,
Cosmic:875903,
Cosmic:887227,
Cosmic:905989,
Cosmic:974247,
Cosmic:1092609,
Cosmic:1175843,
Cosmic:1305356,
Cosmic:1312340,
Cosmic:1436018,
Cosmic:1479631,
Cosmic:1676739,
Cosmic:1805256,
Cosmic:1995469,
Cosmic:1998451,
Cosmic:2301990,
Cosmic:2650775,
Cosmic:2667973,
Cosmic:2811053,
Cosmic-CLP:905989,
DepMap:ACH-000969,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
GDSC:905989,
GEO:GSM2130,
GEO:GSM50191,
GEO:GSM50255,
GEO:GSM206516,
GEO:GSM274781,
GEO:GSM743446,
GEO:GSM750797,
GEO:GSM799334,
GEO:GSM799397,
GEO:GSM844576,
GEO:GSM844577,
GEO:GSM846361,
GEO:GSM887212,
GEO:GSM888286,
GEO:GSM1153404,
GEO:GSM1178291,
GEO:GSM1178292,
GEO:GSM1178293,
GEO:GSM1181253,
GEO:GSM1181266,
GEO:GSM1346877,
GEO:GSM1448073,
GEO:GSM1669988,
GEO:GSM2124659,
GEO:GSM2550006,
IARC_TP53:18072,
IARC_TP53:21119,
LiGeA:CCLE_206,
LINCS_LDP:LCL-1192,
MetaboLights:MTBLS227,
NCI-DTP:KM-12,
PharmacoDB:KM12_753_2019,
PRIDE:PXD003539,
PRIDE:PXD005235,
PRIDE:PXD005942,
PRIDE:PXD005946,
PRIDE:PXD030304,
Progenetix:CVCL_1331,
PubChem_Cell_line:CVCL_1331,
SKY/M-FISH/CGH:2795,
Wikidata:Q54900052 |
|
|
CVCL_1331 |
2026-07-25 04:47:45 |
5 |
KMS-12-BM
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_1334
|
Homo sapiens (Human)
|
Plasma cell myeloma
|
Population: Japanese., Part of: MD Anderson Cell Lines Project., Part of: LL-100 blood cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2479409
PMID:2519219
PMID:2768132
PMID:8695815
PMID:9290701
PMID:10936422
PMID:11039672
PMID:15215163
PMID:16956823
PMID:17171682
PMID:17692805
PMID:18647998
PMID:18700954
PMID:19306352
PMID:21173094
PMID:22460905
PMID:22806891
PMID:25485619
PMID:25688540
PMID:25877200
PMID:25984343
PMID:26589293
PMID:27397505
PMID:28196595
PMID:30285677
PMID:30894373
PMID:31068700
PMID:31160637
PMID:31978347
PMID:32123307
PMID:35839778
|
Cancer cell line
|
Female |
KMS 12 BM, KMS-12BM, KMS12-BM, KMS12BM, KMS-12, KMS12, Kawasaki Medical School-12-Bone Marrow |
|
|
BTO:BTO_0006459,
CLO:CLO_0009842,
EFO:EFO_0006612,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
ArrayExpress:E-MTAB-7721,
ArrayExpress:E-MTAB-7722,
ArrayExpress:E-TABM-1088,
BioSample:SAMN01821691,
BioSample:SAMN03472933,
BioSample:SAMN10988243,
cancercelllines:CVCL_1334,
Cell_Model_Passport:SIDM01020,
CGH-DB:28-1,
CGH-DB:9141-4,
ChEMBL-Cells:CHEMBL4295426,
ChEMBL-Targets:CHEMBL4296455,
CLS:300287,
Cosmic:2081425,
Cosmic:2367302,
Cosmic-CLP:907281,
DepMap:ACH-000380,
DSMZ:ACC-551,
DSMZCellDive:ACC-551,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
GDSC:907281,
GEO:GSM99382,
GEO:GSM143346,
GEO:GSM290295,
GEO:GSM562812,
GEO:GSM887221,
GEO:GSM888295,
GEO:GSM1374601,
GEO:GSM1669994,
IARC_TP53:21435,
IZSLER:BS TCL 240,
JCRB:JCRB0429,
LiGeA:CCLE_244,
LINCS_LDP:LCL-2043,
PharmacoDB:KMS12BM_763_2019,
PRIDE:PXD030239,
PRIDE:PXD030304,
Progenetix:CVCL_1334,
PubChem_Cell_line:CVCL_1334,
Wikidata:Q54900168 |
|
|
CVCL_1334 |
2026-07-25 04:47:48 |
10 |
KMOE-2
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1332
|
Homo sapiens (Human)
|
Erythroleukemia
|
Population: Japanese., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:6949905
PMID:16408098
PMID:20164919
PMID:27397505
PMID:30894373
PMID:35839778
|
Cancer cell line
|
Female |
KMOE2, Kmoe2 |
|
|
CLO:CLO_0007114,
CLDB:cl3034,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-3610,
BioSample:SAMN03473322,
cancercelllines:CVCL_1332,
Cell_Model_Passport:SIDM01019,
ChEMBL-Cells:CHEMBL3308236,
ChEMBL-Targets:CHEMBL2366347,
Cosmic:787445,
Cosmic:907280,
Cosmic:975262,
Cosmic:1012079,
Cosmic:1465969,
Cosmic:2131542,
Cosmic:2306213,
Cosmic-CLP:907280,
DepMap:ACH-002258,
DSMZ:ACC-37,
DSMZCellDive:ACC-37,
EGA:EGAS00001000978,
GDSC:907280,
GEO:GSM1446748,
GEO:GSM1669991,
IARC_TP53:21434,
LINCS_LDP:LCL-1058,
PharmacoDB:KMOE2_757_2019,
PRIDE:PXD030304,
PubChem_Cell_line:CVCL_1332,
Wikidata:Q54900132 |
|
|
CVCL_1332 |
2026-07-25 04:47:47 |
1 |
KMS-11
Resource Report
Resource Website
100+ mentions
Discontinued
|
RRID:CVCL_2989
|
Homo sapiens (Human)
|
Plasma cell myeloma
|
Characteristics: Produces IgG kappa., Population: Japanese., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2519219
PMID:2768132
PMID:8943038
PMID:9787181
PMID:10936422
PMID:11157491
PMID:15215163
PMID:15491288
PMID:16956823
PMID:17171682
PMID:17692805
PMID:18647998
PMID:18700954
PMID:19306352
PMID:21173094
PMID:22460905
PMID:25485619
PMID:25688540
PMID:25877200
PMID:25984343
PMID:26589293
PMID:27397505
PMID:28196595
PMID:30285677
PMID:30545397
PMID:30894373
PMID:30971826
PMID:31068700
PMID:31978347
PMID:32123307
PMID:35839778
|
Cancer cell line
|
Female |
KMS11, kms11, kms 11, Kawasaki Medical School-11 |
|
|
BTO:BTO_0003932,
EFO:EFO_0005694,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
ArrayExpress:E-TABM-1088,
BioGRID_ORCS_Cell_line:911,
BioSample:SAMN03473171,
BioSample:SAMN10987857,
cancercelllines:CVCL_2989,
CCRID:1101HUM-PUMC000682,
Cell_Model_Passport:SIDM00608,
CGH-DB:21-1,
CGH-DB:9133-4,
ChEMBL-Cells:CHEMBL4295454,
ChEMBL-Targets:CHEMBL4296454,
Cosmic:720765,
Cosmic:759900,
Cosmic:759906,
Cosmic:760389,
Cosmic:760402,
Cosmic:760645,
Cosmic:850216,
Cosmic:1740213,
Cosmic:2081391,
Cosmic:2302410,
Cosmic:2367280,
Cosmic:2391798,
Cosmic:2809763,
Cosmic-CLP:1659817,
DepMap:ACH-000714,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
EGA:EGAS00001002414,
EGA:EGAS00001002554,
ENCODE:ENCBS682HMC,
ENCODE:ENCBS987CHP,
GDSC:1659817,
GEO:GSM143337,
GEO:GSM290294,
GEO:GSM562810,
GEO:GSM887220,
GEO:GSM888294,
GEO:GSM1666387,
GEO:GSM1692593,
GEO:GSM1692594,
GEO:GSM1692595,
JCRB:JCRB1179,
JCRB:NIHS0482,
LiGeA:CCLE_189,
PharmacoDB:KMS11_762_2019,
PRIDE:PXD030304,
Progenetix:CVCL_2989,
PubChem_Cell_line:CVCL_2989,
Wikidata:Q54900162 |
|
|
CVCL_2989 |
2026-07-25 04:47:48 |
204 |
KMH-2
Resource Report
Resource Website
1+ mentions
Discontinued
|
RRID:CVCL_S641
|
Homo sapiens (Human)
|
Thyroid gland anaplastic carcinoma
|
Population: Japanese., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:11686581
PMID:20215515
PMID:23833040
PMID:27397505
PMID:30737244
PMID:30894373
PMID:35839778
|
Cancer cell line
|
Male |
KMHDASH2, KMH2 |
|
|
CLO:CLO_0037155,
ArrayExpress:E-MTAB-3610,
BioSample:SAMN03472496,
cancercelllines:CVCL_S641,
CCRID:3101HUMSCSP551,
Cell_Model_Passport:SIDM00619,
CLS:305142,
Cosmic:2054094,
Cosmic-CLP:1298167,
DepMap:ACH-002397,
EGA:EGAS00001000978,
GDSC:1298167,
GEO:GSM827259,
GEO:GSM1669989,
JCRB:JCRB1066,
JCRB:NIHS0268,
LINCS_LDP:LCL-1684,
PharmacoDB:KMH2_755_2019,
PRIDE:PXD030304,
Progenetix:CVCL_S641,
Wikidata:Q54900116 |
|
|
CVCL_S641 |
2026-07-25 04:47:47 |
1 |
KNS-62
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1335
|
Homo sapiens (Human)
|
Lung squamous cell carcinoma
|
Population: Japanese., Part of: TCGA-110-CL cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2203882
PMID:3518877
PMID:6205259
PMID:7358770
PMID:15746151
PMID:20164919
PMID:22460905
PMID:24002593
PMID:25485619
PMID:25877200
PMID:26589293
PMID:27397505
PMID:30894373
PMID:30971826
PMID:31068700
PMID:31395879
PMID:35839778
|
Cancer cell line
|
Male |
KNS62 |
|
|
EFO:EFO_0006620,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
BioGRID_ORCS_Cell_line:616,
BioSample:SAMN03472612,
BioSample:SAMN10987892,
cancercelllines:CVCL_1335,
Cell_Model_Passport:SIDM00606,
ChEMBL-Cells:CHEMBL3308237,
ChEMBL-Targets:CHEMBL2366244,
Cosmic:753569,
Cosmic:1995472,
Cosmic:2060532,
Cosmic-CLP:753569,
DepMap:ACH-000858,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
FANTOM5_SSTAR:10760-110E4,
GDSC:753569,
GEO:GSM274672,
GEO:GSM887231,
GEO:GSM888305,
GEO:GSM1669996,
IARC_TP53:21437,
JCRB:IFO50358,
LiGeA:CCLE_427,
PharmacoDB:KNS62_775_2019,
PRIDE:PXD030304,
Progenetix:CVCL_1335,
PubChem_Cell_line:CVCL_1335,
Wikidata:Q54900252 |
|
|
CVCL_1335 |
2026-07-25 04:47:51 |
2 |
KNS-81-FD
Resource Report
Resource Website
|
RRID:CVCL_1336
|
Homo sapiens (Human)
|
Glioblastoma, IDH-wildtype
|
Population: Japanese., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Serum/protein free medium cell line.
|
PMID:20164919
PMID:25877200
PMID:27397505
PMID:30894373
PMID:35839778
|
Cancer cell line
|
Male |
KNS-81FD, KNS81FD |
|
|
CLO:CLO_0009895,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-3610,
BioSamples:SAMEA1284015,
cancercelllines:CVCL_1336,
Cell_Model_Passport:SIDM01210,
ChEMBL-Cells:CHEMBL3308306,
ChEMBL-Targets:CHEMBL2366203,
Cosmic:924188,
Cosmic:2367534,
Cosmic-CLP:924188,
DepMap:ACH-002259,
EGA:EGAS00001000978,
GDSC:924188,
GEO:GSM1669997,
IARC_TP53:27561,
JCRB:IFO50444,
LINCS_LDP:LCL-1383,
PharmacoDB:KNS81FD_776_2019,
PRIDE:PXD030304,
PubChem_Cell_line:CVCL_1336,
Wikidata:Q54900254 |
cvcl_2799 |
|
CVCL_1336 |
2026-07-25 04:47:51 |
0 |
KNS-42
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_0378
|
Homo sapiens (Human)
|
Glioblastoma, IDH-wildtype
|
Population: Japanese., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2448680
PMID:16232199
PMID:19365568
PMID:20164919
PMID:22460905
PMID:25401693
PMID:25628092
PMID:26589293
PMID:27397505
PMID:30894373
PMID:30971826
PMID:31068700
PMID:31978347
PMID:34078608
PMID:35839778
|
Cancer cell line
|
Male |
KNS42 |
|
|
BTO:BTO_0005859,
CLO:CLO_0009894,
MCCL:MCC:0000273,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
BCRJ:0295,
BioGRID_ORCS_Cell_line:617,
BioSample:SAMN03472787,
BioSample:SAMN10987931,
cancercelllines:CVCL_0378,
Cell_Model_Passport:SIDM00607,
CGH-DB:144-1,
ChEMBL-Cells:CHEMBL3308538,
ChEMBL-Targets:CHEMBL2366261,
Cosmic:687573,
Cosmic:907282,
Cosmic:2367532,
Cosmic-CLP:907282,
DepMap:ACH-000622,
EGA:EGAS00001000978,
GDSC:907282,
GEO:GSM887229,
GEO:GSM888303,
GEO:GSM1669995,
GEO:GSM2197880,
GEO:GSM2197881,
GEO:GSM2197882,
GEO:GSM2197883,
GEO:GSM2197884,
GEO:GSM2197885,
GEO:GSM4969600,
GEO:GSM4969601,
GEO:GSM4969617,
GEO:GSM4969634,
GEO:GSM4969635,
GEO:GSM4969636,
GEO:GSM5356021,
IARC_TP53:21436,
JCRB:IFO50356,
LiGeA:CCLE_847,
LINCS_LDP:LCL-1382,
PharmacoDB:KNS42_773_2019,
PRIDE:PXD030304,
Progenetix:CVCL_0378,
PubChem_Cell_line:CVCL_0378,
Wikidata:Q54900250 |
|
|
CVCL_0378 |
2026-07-25 04:47:51 |
10 |
KP-N-YN
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1341
|
Homo sapiens (Human)
|
Adrenal gland neuroblastoma
|
Population: Japanese., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2019470
PMID:12702577
PMID:20164919
PMID:22460905
PMID:23268333
PMID:25877200
PMID:26589293
PMID:27397505
PMID:30894373
PMID:30971826
PMID:31068700
PMID:35839778
|
Cancer cell line
|
Male |
KPNYN, Kyoto Pediatrics-Neuroblastoma-YN |
|
|
BTO:BTO_0003546,
CLO:CLO_0037079,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
BioGRID_ORCS_Cell_line:610,
BioSample:SAMN03470961,
BioSample:SAMN10988113,
cancercelllines:CVCL_1341,
Cell_Model_Passport:SIDM00556,
CGH-DB:80-1,
CGH-DB:9082-4,
ChEMBL-Cells:CHEMBL3308265,
ChEMBL-Targets:CHEMBL2366280,
Cosmic:907314,
Cosmic-CLP:907314,
DepMap:ACH-000227,
EGA:EGAS00001000978,
GDSC:907314,
GEO:GSM887241,
GEO:GSM888315,
GEO:GSM1670007,
IARC_TP53:21442,
JCRB:IFO50431,
LiGeA:CCLE_699,
LINCS_LDP:LCL-1985,
PharmacoDB:KPNYN_788_2019,
PRIDE:PXD030304,
Progenetix:CVCL_1341,
PubChem_Cell_line:CVCL_1341,
Wikidata:Q54900402 |
|
|
CVCL_1341 |
2026-07-25 04:47:54 |
2 |
KP-N-RT-BM-1
Resource Report
Resource Website
1+ mentions
|
JCRB Cat# IFO50432, RRID:CVCL_1339
|
Homo sapiens (Human)
|
Adrenal gland neuroblastoma
|
Population: Japanese., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:3731124
PMID:10628353
PMID:11129446
PMID:11501497
PMID:12702577
PMID:15892104
PMID:20164919
PMID:22460905
PMID:23268333
PMID:25877200
PMID:26589293
PMID:27397505
PMID:30894373
PMID:31068700
PMID:35839778
|
Cancer cell line
|
Female |
KPNRTBM1, KP-N-RT(BM1), RT-BM-1, RT-BM 1, RTBM1, KP-N-RT-BM, KP-N-RTBM, RT-BM, BM1, KP-N-RT, Kyoto Pediatrics-Neuroblastoma-RT-Bone Marrow |
JCRB |
IFO50432 |
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2770,
BioSample:SAMN03470963,
BioSample:SAMN10987720,
cancercelllines:CVCL_1339,
Cell_Model_Passport:SIDM00557,
CGH-DB:69-1,
CGH-DB:9079-4,
ChEMBL-Cells:CHEMBL3308339,
ChEMBL-Targets:CHEMBL2366107,
Cosmic:848926,
Cosmic:924189,
Cosmic-CLP:924189,
DepMap:ACH-000345,
GDSC:924189,
GEO:GSM887239,
GEO:GSM888313,
GEO:GSM1670005,
IARC_TP53:27697,
JCRB:IFO50432,
LiGeA:CCLE_682,
PharmacoDB:KPNRTBM1_786_2019,
PRIDE:PXD030304,
Progenetix:CVCL_1339,
PubChem_Cell_line:CVCL_1339,
Wikidata:Q54900391 |
|
|
CVCL_1339 |
2026-07-25 04:47:54 |
1 |
KP-2
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_3004
|
Homo sapiens (Human)
|
Pancreatic carcinoma
|
Population: Japanese., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2172194
PMID:18380791
PMID:21607521
PMID:22460905
PMID:25485619
PMID:25877200
PMID:25984343
PMID:26216984
PMID:26589293
PMID:27397505
PMID:30894373
PMID:31068700
PMID:31978347
PMID:35839778
|
Cancer cell line
|
Female |
KP2 |
|
|
BTO:BTO_0003550,
CLO:CLO_0037107,
EFO:EFO_0006621,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
BioGRID_ORCS_Cell_line:615,
BioSample:SAMN03472830,
BioSample:SAMN03472944,
BioSample:SAMN10988261,
cancercelllines:CVCL_3004,
Cell_Model_Passport:SIDM00582,
CGH-DB:175-1,
CGH-DB:9370-4,
Cosmic:918057,
Cosmic-CLP:1298218,
DepMap:ACH-000281,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
GDSC:1298218,
GEO:GSM887235,
GEO:GSM888309,
IARC_TP53:28361,
JCRB:JCRB0181,
LiGeA:CCLE_694,
LINCS_LDP:LCL-1728,
PharmacoDB:KP2_783_2019,
PRIDE:PXD030304,
Progenetix:CVCL_3004,
Wikidata:Q54900359 |
|
|
CVCL_3004 |
2026-07-25 04:47:53 |
6 |
KP-1N
Resource Report
Resource Website
Contaminated
|
RRID:CVCL_3002
|
Homo sapiens (Human)
|
Pancreatic ductal adenocarcinoma
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Problematic cell line: Contaminated. Shown to be a PANC-1 derivative..
|
PMID:2172194
PMID:18380791
PMID:20215515
PMID:21607521
PMID:27397505
PMID:29444439
PMID:30894373
PMID:30971826
PMID:31068700
PMID:35839778
|
Cancer cell line
|
Male |
Kp-1N, KP-1 N, KP1N, KP1 |
|
|
BTO:BTO_0003549,
CLO:CLO_0037105,
ArrayExpress:E-MTAB-3610,
BioGRID_ORCS_Cell_line:914,
BioSample:SAMN03151887,
BioSample:SAMN10989578,
cancercelllines:CVCL_3002,
Cell_Model_Passport:SIDM00583,
CGH-DB:173-1,
CGH-DB:9368-4,
Cosmic:918052,
Cosmic:1122345,
Cosmic:1518234,
Cosmic:1995474,
Cosmic-CLP:1298216,
DepMap:ACH-001107,
EGA:EGAS00001000978,
GDSC:1298216,
GEO:GSM827208,
GEO:GSM1670002,
IARC_TP53:30107,
JCRB:JCRB0177.0,
JCRB:NIHS0274.0,
LINCS_LDP:LCL-1793,
PharmacoDB:KP1N_781_2019,
PRIDE:PXD030304,
Progenetix:CVCL_3002,
Wikidata:Q54900356 |
cvcl_0480 |
|
CVCL_3002 |
2026-07-25 04:47:53 |
0 |
